Redmile Group’s Electra Therapeutics ETRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ETRA
Redmile Group's ETRA Position: Q3 2026 in Review
Redmile Group opened a new position in Electra Therapeutics (ETRA) in Q3 2026: 5,430,918 shares worth $61.1M. The stake represents 4.47% of the portfolio and ranks #7 among its holdings.
59 funds tracked by Wall St. Rank hold ETRA as of Q3 2026.
- Redmile Group held 5,430,918 shares of Electra Therapeutics worth $61.1M as of Q3 2026.
- Electra Therapeutics was a new Redmile Group position in Q3 2026.
- Electra Therapeutics made up 4.47% of Redmile Group's portfolio in Q3 2026, its #7 holding.
- 59 funds tracked by Wall St. Rank held Electra Therapeutics as of Q3 2026.
Based on Redmile Group's 13F filing for Q3 2026, filed 16 Nov 2026.